Yigal Nochomovitz
Stock Analyst at Citigroup
(2.33)
# 2,579
Out of 4,896 analysts
300
Total ratings
40.08%
Success rate
-0.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROK ProKidney | Maintains: Buy | $6 → $9 | $4.54 | +98.24% | 2 | Jul 9, 2025 | |
| SLDB Solid Biosciences | Initiates: Buy | $14 | $5.26 | +166.16% | 1 | Jun 26, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $49 → $41 | $19.44 | +110.91% | 15 | May 22, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $215 → $155 | $148.17 | +4.61% | 5 | May 16, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $7.79 | +21.95% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $4.49 | +122.72% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $25.00 | +40.00% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $34.69 | +35.49% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $13.34 | +42.43% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.88 | +191.31% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $42 | $9.59 | +337.96% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.81 | +330.29% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $56.80 | +44.37% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $10.36 | +218.53% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $54.54 | +77.85% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.41 | +1,832.83% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.63 | +268.10% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $11.18 | +141.50% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.82 | +145.25% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $21.63 | +66.44% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $22.46 | +158.24% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $2.00 | +1,000.00% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.61 | +769.57% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.41 | +196.30% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $9.33 | +307.29% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $11.12 | +25.96% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.32 | -13.79% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $32.73 | +101.65% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $13.78 | +248.33% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.65 | +330.11% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $4.65 | +72.04% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.80 | -73.68% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $9.19 | +280.85% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $29.51 | +350.69% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $1.08 | +640.74% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.11 | +5,354.55% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.59 | +906.29% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.15 | +769.57% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.80 | +566.67% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.39 | - | 14 | Sep 28, 2021 |
ProKidney
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $4.54
Upside: +98.24%
Solid Biosciences
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $5.26
Upside: +166.16%
Apellis Pharmaceuticals
May 22, 2025
Maintains: Buy
Price Target: $49 → $41
Current: $19.44
Upside: +110.91%
Krystal Biotech
May 16, 2025
Maintains: Neutral
Price Target: $215 → $155
Current: $148.17
Upside: +4.61%
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.79
Upside: +21.95%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $4.49
Upside: +122.72%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $25.00
Upside: +40.00%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $34.69
Upside: +35.49%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $13.34
Upside: +42.43%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.88
Upside: +191.31%
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $9.59
Upside: +337.96%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.81
Upside: +330.29%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $56.80
Upside: +44.37%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $10.36
Upside: +218.53%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $54.54
Upside: +77.85%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.41
Upside: +1,832.83%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.63
Upside: +268.10%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $11.18
Upside: +141.50%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.82
Upside: +145.25%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $21.63
Upside: +66.44%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $22.46
Upside: +158.24%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $2.00
Upside: +1,000.00%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.61
Upside: +769.57%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.41
Upside: +196.30%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $9.33
Upside: +307.29%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $11.12
Upside: +25.96%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.32
Upside: -13.79%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $32.73
Upside: +101.65%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $13.78
Upside: +248.33%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.65
Upside: +330.11%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $4.65
Upside: +72.04%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.80
Upside: -73.68%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $9.19
Upside: +280.85%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $29.51
Upside: +350.69%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $1.08
Upside: +640.74%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.11
Upside: +5,354.55%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.59
Upside: +906.29%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.15
Upside: +769.57%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.80
Upside: +566.67%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.39
Upside: -